ChiollazAC, PouillardV, SeilerM, et al.IL6 in combination with either NfL, NTproBNP, or GFAP to safely discharge children with mild traumatic brain injury. J Neurotrauma, 2026; 43(3–4):248–258.
2.
LoTYM, JonesPA, MinnsRA. Pediatric brain trauma outcome prediction using paired serum levels of inflammatory mediators and brain-specific proteins. J Neurotrauma, 2009; 26(9):1479–1487.
3.
ParkSH, HwangSK. Prognostic value of serum levels of S100 calcium-binding protein B, neuron-specific enolase, and interleukin-6 in pediatric patients with traumatic brain injury. World Neurosurg, 2018; 118:e534–e542.
4.
SamantaRJ, ChiollazAC, NeedhamE, et al.; CENTER-TBI investigators and participants. Parsimonious immune-response endotypes and global outcome in patients with traumatic brain injury. EBioMedicine, 2024; 108:105310.
5.
ShorePM, BergerRP, VarmaS, et al.Cerebrospinal fluid biomarkers versus Glasgow Coma Scale and Glasgow Outcome Scale in pediatric traumatic brain injury: The role of young age and inflicted injury. J Neurotrauma, 2007; 24(1):75–86.
